Prof Patrick W. Serruys (Imperial College London, London, UK) discusses sub-analyses from the GLOBAL LEADERS study - long-term ticagrelor monotherapy for 23 months following one-month DAPT after PCI in complex clinical scenarios.
Filmed on site at EuroPCR 2019 by Radcliffe Cardiology.
1. Would you remind us of the GLOBAL LEADERS study design?
2. What sub-analyses are you presenting at EuroPCR 2019? How should this data be interpreted?
Videography: Mike Knight
Interviewer: Liam O'Neill